drugset / Trial / NCT00437372
Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Phase 1
Completed
39 enrolled
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Pfizer · collab
NaSingle-groupOpen-labelTreatment
Summary
This study is using the combination of radiation and antiangiogenic agents (agents that destroy existing blood vessels) seems to be an approach to tumor cure.
Timeline
- Start
- 2007-03
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sunitinib | Small molecule | — | — |